Dement Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Dement clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 230 trials

Recruiting
Not Applicable

Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care

DepressionAnxietyPsychosis+1 more
Brigham and Women's Hospital45 enrolled3 locationsNCT07364825
Recruiting

Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study

Diabete Type 2Alzheimer Dementia (AD)
Rigshospitalet, Denmark60 enrolled1 locationNCT07482072
Recruiting
Phase 1

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Multiple System AtrophyParkinson DiseaseDementia With Lewy Bodies+2 more
Daniel Claassen40 enrolled1 locationNCT04246437
Recruiting
Phase 2

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

Alzheimer DementiaLate Onset Alzheimer DiseaseNeurodegenerative Diseases
University of Arizona100 enrolled10 locationsNCT04838301
Recruiting
Not Applicable

Social-cognitive Functioning: Validation of a New Neuropsychological Test

Frontotemporal Degeneration(FTD)Alzheimer's Disease(AD)Lewy Body Dementia (LBD)
Assistance Publique - Hôpitaux de Paris120 enrolled1 locationNCT05558709
Recruiting
Not Applicable

Dementia Caregivers' Link to Assistance and Resources

DementiaAlzheimer Disease or Associated Disorder
Visiting Nurse Service of New York200 enrolled1 locationNCT06860035
Recruiting
Phase 3

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting

Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders

Cognitive Impairment, MildApathy in DementiaApathy+2 more
KompanionCare SAS80 enrolled5 locationsNCT07237009
Recruiting
Phase 4

Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia

Dementia With Lewy BodiesParkinson Disease DementiaHealthy (Controls)
Virginia Commonwealth University120 enrolled1 locationNCT07284290
Recruiting
Not Applicable

Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.

DementiaCaregiver BurdenCaregiver Burnout
University of Southern California80 enrolled1 locationNCT06418971
Recruiting
Not Applicable

Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's

DementiaAnxietyAlzheimer Disease+1 more
Florida State University388 enrolled3 locationsNCT05748613
Recruiting
Phase 3

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

Type 2 DiabetesDementia, MildMild Cognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School420 enrolled8 locationsNCT07083154
Recruiting
Phase 2Phase 3

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

Agitation Associated With Alzheimer's Disease Dementia
Exciva GmbH300 enrolled13 locationsNCT07284472
Recruiting

Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)

Alzheimer DiseaseOld Age; Dementia
Istituto Nazionale di Ricovero e Cura per Anziani400 enrolled3 locationsNCT07435467
Recruiting

CUHK Brain Health Longitudinal Study

DementiaBrain DiseasesHealth Knowledge, Attitudes, Practice+9 more
Chinese University of Hong Kong5,000 enrolled2 locationsNCT03592563
Recruiting

Impact of COVID-19 Vaccines on Cerebrovascular Health

DementiaBrain DiseasesStroke, Ischemic+7 more
Chinese University of Hong Kong500 enrolled1 locationNCT04992195
Recruiting

German Dementia Registry

Dementia Disorder
RWTH Aachen University5,000 enrolled24 locationsNCT07433010
Recruiting

Circadian Rhythm and Other Factors in Memory Clinic Patients

Dementia
Assistance Publique - Hôpitaux de Paris1,200 enrolled2 locationsNCT05977712
Recruiting

Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia

Alzheimer's Disease (AD)Financial HardshipAlzheimer's Disease and Related Dementia (ADRD)
Fred Hutchinson Cancer Center2,460 enrolled1 locationNCT06922188
Recruiting
Phase 1

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

DementiaALSMild Cognitive Impairment+2 more
National Institute of Mental Health (NIMH)184 enrolled1 locationNCT04396873